49m
Stockhead on MSNRace initiates first site for Phase I trial of cardioprotective anticancer drugSouthside Cancer Care Centre in Miranda initiated as first site for Race’s Phase I trial of cardioprotective therapy RC220 in ...
Del Villar and his talent agency, Del Entertainment, were found guilty of conspiring to violate a federal law that prohibits ...
Trial lawyers, especially defense lawyers in the pharmaceutical and medical device arena, strive to ensure that “junk science” stays out of ...
Wave Life Sciences Ltd. shares promising updates on AATD & DMD treatments. Click here for my updated look at WVE stock ...
Drug development programs face unique challenges in demonstrating the safety and effectiveness of drugs for treating rare diseases. The ...
The main reason pre-workout supplements might not be the best for your health is because of their high caffeine content. Here ...
10h
Zacks Investment Research on MSNFDA Expands Exelixis Cabometyx Label for Neuroendocrine TumorsExelixis, Inc. EXEL announced that the FDA has approved the label expansion of its lead drug Cabometyx (cabozantinib). The ...
Diazoxide choline is the first drug indicated for hyperphagia in the rare genetic disorder. Prior to approval, people with ...
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
The web page comprises questions the FDA received from stakeholders, including industry, trade associations and consumers, ...
The Senate on Tuesday voted to confirm President Trump’s nomination of Martin Makary as the commissioner of the Food and Drug ...
Approval was based on findings from the pivotal CABINET trial showing improved PFS and response rates vs placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results